Liu et al. indicated that HULC can elevate HBx, which co-activated the STAT3 to stimulate the miR-539 promoter, and then down regulated APOBEC3B to activate HBV in HBV-related hepatocellular carcinoma [61]. This evidence concerns the gene APOBEC3B and hepatocellular carcinoma.